Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Gregory Y H
GY
Lip
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D002908:Chronic Disease; D006470:Hemorrhage / Q000453:epidemiology*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000628:therapy; D006435:Renal Dialysis; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology*; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin